SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 480.64 |
| Enterprise Value ($M) | 485.51 |
| Book Value ($M) | 69.77 |
| Book Value / Share | 1.31 |
| Price / Book | 6.89 |
| NCAV ($M) | -22.34 |
| NCAV / Share | -0.42 |
| Price / NCAV | -21.52 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.69 |
| Return on Assets (ROA) | -0.65 |
| Return on Equity (ROE) | -1.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.88 |
| Current Ratio | 2.88 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 99.44 |
| Assets | 191.55 |
| Liabilities | 121.78 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Woodline Partners LP | 7.70 | ||
| 13G/A | Vanguard Group Inc | 5.23 | 0.00 | |
| 13G | Nantahala Capital Management, LLC | 6.20 | ||
| 13G | BlackRock, Inc. | 5.80 | 182.62 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 172,598 | 1,289,977 | 13.38 | |
| 136,750 | 881,531 | 15.51 | |
| 174,168 | 1,070,280 | 16.27 | |
| 176,814 | 885,713 | 19.96 | |
| 111,585 | 540,832 | 20.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| XERS – Xeris Biopharma Holdings, Inc. | XLO – Xilio Therapeutics, Inc. |
| YMAB – Y-mAbs Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io